Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
Background: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/4/518 |
id |
doaj-725e40088d8c458190a3090896ce8911 |
---|---|
record_format |
Article |
spelling |
doaj-725e40088d8c458190a3090896ce89112020-11-24T22:11:29ZengMDPI AGJournal of Clinical Medicine2077-03832019-04-018451810.3390/jcm8040518jcm8040518Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary MacroadenomaPing-Kun Hsiao0Chia-Lun Chang1Kevin Sheng-Po Yuan2Alexander T.H. Wu3Szu-Yuan Wu4Department of General Surgery, Wan Fang Hospital, Taipei Medical University, Taipei 11031, TaiwanDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanDepartment of Otorhinolaryngology, Wan Fang Hospital, Taipei Medical University, Taipei 11031, TaiwanPh.D. Program for Translational Medicine, Taipei Medical University, Taipei 11031, TaiwanDepartment of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanBackground: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, the patients were categorized into three groups according to the treatment modality: group 1, patients receiving modern FRT; group 2, patients receiving contemporary SRS; and group 3, patients receiving transsphenoidal surgery. Results: In total, 548 patients with nonfunctioning pituitary macroadenoma were selected for our study. Univariate and multivariate Cox regression analysis results indicated that the treatment modalities were significant independent prognostic factors. In multivariable Cox proportional hazard regression analysis, the adjusted hazard ratios (aHR; 95% confidence interval (CI)) of local recurrence were 0.27 (0.10–0.91) and 1.95 (1.25–2.37) for the SRS and transsphenoidal surgery cohorts, respectively, in comparison with the FRT cohort. The aHR (95% CI) of all-cause mortality was 1.03 (0.68–1.56) for the transsphenoidal surgery cohort in comparison with the FRT cohort, without statistical significance. However, the aHR (95% CI) of all-cause mortality was 0.36 (0.15–0.85) for the SRS cohort in comparison with the FRT cohort. Conclusion: Contemporary SRS has optimal effects on local recurrence and survival compared with modern FRT and transsphenoidal surgery. Modern FRT is associated with more favorable local control and equal survival compared with transsphenoidal surgery.https://www.mdpi.com/2077-0383/8/4/518nonfunctioning pituitary macroadenomatranssphenoidal surgerystereotactic radiosurgeryfractionated radiotherapyrecurrencemortality |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ping-Kun Hsiao Chia-Lun Chang Kevin Sheng-Po Yuan Alexander T.H. Wu Szu-Yuan Wu |
spellingShingle |
Ping-Kun Hsiao Chia-Lun Chang Kevin Sheng-Po Yuan Alexander T.H. Wu Szu-Yuan Wu Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma Journal of Clinical Medicine nonfunctioning pituitary macroadenoma transsphenoidal surgery stereotactic radiosurgery fractionated radiotherapy recurrence mortality |
author_facet |
Ping-Kun Hsiao Chia-Lun Chang Kevin Sheng-Po Yuan Alexander T.H. Wu Szu-Yuan Wu |
author_sort |
Ping-Kun Hsiao |
title |
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma |
title_short |
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma |
title_full |
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma |
title_fullStr |
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma |
title_full_unstemmed |
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma |
title_sort |
results of treatment with modern fractionated radiotherapy, contemporary stereotactic radiosurgery, and transsphenoidal surgery in nonfunctioning pituitary macroadenoma |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-04-01 |
description |
Background: To compare the effects of contemporary stereotactic radiosurgery (SRS), modern fractionated radiotherapy (FRT), and transsphenoidal surgery on nonfunctioning pituitary macroadenoma. Methods: We enrolled patients with nonfunctioning pituitary macroadenoma. To compare treatment outcomes, the patients were categorized into three groups according to the treatment modality: group 1, patients receiving modern FRT; group 2, patients receiving contemporary SRS; and group 3, patients receiving transsphenoidal surgery. Results: In total, 548 patients with nonfunctioning pituitary macroadenoma were selected for our study. Univariate and multivariate Cox regression analysis results indicated that the treatment modalities were significant independent prognostic factors. In multivariable Cox proportional hazard regression analysis, the adjusted hazard ratios (aHR; 95% confidence interval (CI)) of local recurrence were 0.27 (0.10–0.91) and 1.95 (1.25–2.37) for the SRS and transsphenoidal surgery cohorts, respectively, in comparison with the FRT cohort. The aHR (95% CI) of all-cause mortality was 1.03 (0.68–1.56) for the transsphenoidal surgery cohort in comparison with the FRT cohort, without statistical significance. However, the aHR (95% CI) of all-cause mortality was 0.36 (0.15–0.85) for the SRS cohort in comparison with the FRT cohort. Conclusion: Contemporary SRS has optimal effects on local recurrence and survival compared with modern FRT and transsphenoidal surgery. Modern FRT is associated with more favorable local control and equal survival compared with transsphenoidal surgery. |
topic |
nonfunctioning pituitary macroadenoma transsphenoidal surgery stereotactic radiosurgery fractionated radiotherapy recurrence mortality |
url |
https://www.mdpi.com/2077-0383/8/4/518 |
work_keys_str_mv |
AT pingkunhsiao resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma AT chialunchang resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma AT kevinshengpoyuan resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma AT alexanderthwu resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma AT szuyuanwu resultsoftreatmentwithmodernfractionatedradiotherapycontemporarystereotacticradiosurgeryandtranssphenoidalsurgeryinnonfunctioningpituitarymacroadenoma |
_version_ |
1725805379438247936 |